Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Roger Lowe at rlowe@usagainstalzheimers.org or 202.494.3051

  • April 09, 2021

    UsAgainstAlzheimer’s Applauds Proposed Advanced Research Projects Agency for Health to Spur Federal Alzheimer’s Research

    UsAgainstAlzheimer’s issued the following statement applauding the Biden Administration proposal for a...

    Read more
  • April 05, 2021

    UsAgainstAlzheimer’s Statement on FDA Failure to Approve Acadia Drug for Treatment of Dementia-related Hallucinations and Delusions

    We are extremely frustrated and disappointed that the FDA has failed to...

    Read more
  • March 31, 2021

    UsAgainstAlzheimer’s Applauds Biden Administration Infrastructure Proposals for Public Health, Research and the Care Economy

    We applaud the Biden administration's commitment to building essential public health and...

    Read more
  • March 31, 2021

    New Brain Health Guide with Memory Questionnaire Addresses Immense Need for Brain Health Information and Insights about Cognitive Impairment and Alzheimer’s Disease

    Millions of Americans who worry about memory or brain health now have...

    Read more
  • March 18, 2021

    UsAgainstAlzheimer’s Welcomes Confirmation of Xavier Becerra as Secretary of Health and Human Services

    UsAgainstAlzheimer’s issued the following statement by George Vradenburg, chairman and co-founder, on...

    Read more
  • March 15, 2021

    A Year of Stress, Isolation and Decline: New Survey Spotlights Effects of COVID-19 Pandemic on Alzheimer’s Patients and Caregivers

    A new UsAgainstAlzheimer’s A-LIST® survey shows the coronavirus pandemic and related closures...

    Read more
  • March 13, 2021

    UsAgainstAlzheimer’s Statement on Promising Results for Donanemab in Slowing Decline in Early Alzheimer’s Patients

    UsAgainstAlzheimer’s issued the following statement on the release by Eli Lilly of...

    Read more
  • March 08, 2021

    UsAgainstAlzheimer’s Statement on the Retirement Announcement of Sen. Roy Blunt

    “Roy Blunt is a true champion in the fight to stop Alzheimer’s...

    Read more
  • February 10, 2021

    UsAgainstAlzheimer’s Calls for $289 Million Increase in FY22 Federal Spending for NIH Alzheimer’s Research

    UsAgainstAlzheimer’s released the following statement on the Alzheimer’s community’s recommended $289 million...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.